Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 10 matching records.
10 results — page 1 of 1
- Level DLaboratory StudyPubMed
Gingival mesenchymal stem cells: Biological properties and therapeutic applications.
Laboratory Study on Ligament Injury, published in J Oral Biol Craniofac Res (2024) — summary generated from the PubMed abstract.
- 2024
J Oral Biol Craniofac Res18 citations - Level DNarrative ReviewEurope PMC
Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications
Narrative Review on Scar, Immune Modulation, Autoimmune Research, published in Cell Mol Immunol (2023) — summary generated from the PubMed abstract.
- 2023
Cell Mol Immunol157 citations - Level DNarrative ReviewPubMed
Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success.
Narrative Review on Systemic / IV, published in Biomedicines (2021) — summary generated from the PubMed abstract.
- 2021
Biomedicines56 citations - Level DAnimal StudyPubMed
Adipose tissue-derived mesenchymal stem cells rescue the function of islets transplanted in sub-therapeutic numbers via their angiogenic properties.
Animal Study on Systemic / IV, published in Cell Tissue Res (2019) — summary generated from the PubMed abstract.
- 2019
Cell Tissue Res23 citations - Level DNarrative ReviewPubMed
Therapeutic Properties of Mesenchymal Stem Cell on Organ Ischemia-Reperfusion Injury.
Narrative Review, published in Int J Mol Sci (2019) — summary generated from the PubMed abstract.
- 2019
Int J Mol Sci37 citations - Level DAnimal StudyPubMed
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment.
Animal Study, published in Stem Cells Int (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Int125 citations - Level DNarrative ReviewPubMed
Mesenchymal stromal cells with enhanced therapeutic properties.
Narrative Review on Immune Modulation, Autoimmune Research, published in Immunotherapy (2016) — summary generated from the PubMed abstract.
- 2016
Immunotherapy - Level DAnimal StudyEurope PMC
Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning
Animal Study on Cardiovascular Disease, published in Stem Cells (2014) — summary generated from the PubMed abstract.
- 2014
Stem Cells64 citations - Level BClinical TrialEurope PMC
The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential
Clinical Trial, published in Br Med Bull (2013) — summary generated from the PubMed abstract.
- 2013
Br Med Bull196 citations - Level DNarrative ReviewPubMed
Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Narrative Review on Tendon Injury, Neuroinflammation, Immune Modulation, Autoimmune Research, published in Arch Pharm Res (2012) — summary generated from the PubMed abstract.
- 2012
Arch Pharm Res
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406